Please assess the completion status of the following clinical trial:

Trial Title: Resveratrol for Pain Due to Endometriosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Endometriosis diagnosed by laparoscopy~Exclusion Criteria:~* Known allergy to resveratrol~* Use of gonadotropin or danazol in the last month

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- placebo (Type: PLACEBO_COMPARATOR): Patients will take once a day a monophasic pill (ethinylestradiol + levonorgestrel) continuously for 42 days with 1 pill of placebo (starch)
- resveratrol (Type: EXPERIMENTAL): Patients will take once a day a monophasic pill (ethinylestradiol + levonorgestrel) continuously for 42 days with 40mg of resveratrol

Based on this trial design, predict the completion outcome and termination type (if applicable).